"Recognized at a national level for the quality care we're providing, Mary Rutan Hospital is ready to deliver the best care to you and your family. For more than 100 years, Mary Rutan Hospital has continuously improved and developed services to best meet your needs."

During the past decade, Mary Rutan Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 69 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mary Rutan Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 45 trials, followed by "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "SWOG Cancer Research Network" with 23 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Rutan Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Mary Rutan Hospital" are "Breast Cancer" (15 trials), "Lymphoma" (10 trials), "Lung Cancer" (9 trials), "Leukemia" (6 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Mary Rutan Hospital" in a lesser frequency.

Most popular intervention types in "Mary Rutan Hospital" are "Drug" (82 trials), "Other" (58 trials), "Biological" (46 trials), "Procedure" (11 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Bevacizumab" (18 trials), "Quality-of-Life Assessment" (13 trials), "Paclitaxel" (12 trials) and "placebo" (12 trials). Other intervention names were less common.

The vast majority of trials in "Mary Rutan Hospital" are 83 trials for "All" genders, 20 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mary Rutan Hospital". undefined are not yet recruiting, undefined are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Mary Rutan Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Mary Rutan Hospital, 1 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".